These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15644593)

  • 1. SCH00013, a novel Ca(2+) sensitizer with positive inotropic and no chronotropic action in heart failure.
    Tadano N; Morimoto S; Yoshimura A; Miura M; Yoshioka K; Sakato M; Ohtsuki I; Miwa Y; Takahashi-Yanaga F; Sasaguri T
    J Pharmacol Sci; 2005 Jan; 97(1):53-60. PubMed ID: 15644593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 3rd communication: stereoselectivity of the enantiomers in cardiovascular effects.
    Sugawara H; Hino M; Yoshimura A; Yoshioka K; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):412-9. PubMed ID: 10367103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of SCH00013: a novel Ca2+ sensitizer.
    Endoh M; Sugawara H; Mineshima M
    Cardiovasc Drug Rev; 2001; 19(4):345-66. PubMed ID: 11830752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 2nd communication: in vivo cardiovascular effects and bioavailability in dogs.
    Yoshimura A; Koide Y; Yoshioka K; Hino M; Sugawara H; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):407-11. PubMed ID: 10367102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cardiotonic agent SCH00013 acts as a Ca++ sensitizer with no chronotropic activity in mammalian cardiac muscle.
    Sugawara H; Endoh M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):214-22. PubMed ID: 9765340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of calcium-sensitizing agents, pimobendan and SCH00013, on the myocardial function of canine pacing-induced model of heart failure.
    Hamabe L; Kawamura K; Kim SM; Yoshiyuki R; Fukayama T; Shimizu M; Fukushima R; Tanaka R
    J Pharmacol Sci; 2014; 124(3):386-93. PubMed ID: 24599141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart.
    Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 4th communication: influence on experimentally induced ventricular arrhythmia in dogs.
    Yoshimura A; Yoshioka K; Hino M; Sugawara H; Sakato M; Endoh M
    Arzneimittelforschung; 1999 May; 49(5):420-6. PubMed ID: 10367104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction.
    Udvary E; Papp JG; Végh A
    Br J Pharmacol; 1995 Feb; 114(3):656-61. PubMed ID: 7735692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotonic agent SCH00013 prolongs survival of cardiomyopathic hamsters.
    Narita T; Yui R; Koide Y; Sakato M; Kawashima S
    J Cardiovasc Pharmacol; 2003 Sep; 42(3):364-71. PubMed ID: 12960681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac profile of EGIS-9377, a novel cardiotonic agent as a Ca2+ sensitizer with bradycardiac activity.
    Hattori Y; Ishitani T; Tomita F; Gando S; Yokoshiki H; Azuma M; Kemmotsu O; Kanno M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):585-90. PubMed ID: 10598798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure.
    Ekelund UE; Harrison RW; Shokek O; Thakkar RN; Tunin RS; Senzaki H; Kass DA; Marbán E; Hare JM
    Circ Res; 1999 Sep; 85(5):437-45. PubMed ID: 10473673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure.
    Ohte N; Cheng CP; Suzuki M; Little WC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):23-31. PubMed ID: 9223536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs.
    Masutani S; Cheng HJ; Hyttilä-Hopponen M; Levijoki J; Heikkilä A; Vuorela A; Little WC; Cheng CP
    J Pharmacol Exp Ther; 2008 Apr; 325(1):236-47. PubMed ID: 18174383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure.
    Nonaka M; Morimoto S; Murayama T; Kurebayashi N; Li L; Wang YY; Arioka M; Yoshihara T; Takahashi-Yanaga F; Sasaguri T
    Br J Pharmacol; 2015 May; 172(9):2369-82. PubMed ID: 25560565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.
    Furukawa Y; Akahane K; Haniuda M; Chiba S
    Jpn Heart J; 1989 May; 30(3):387-98. PubMed ID: 2552190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose-response study of levosimendan in a porcine model of acute ischaemic heart failure.
    Kolseth SM; Wahba A; Kirkeby-Garstad I; Aro S; Nordgaard H; Høydal M; Rognmo Ø; Nordhaug D
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):1377-83. PubMed ID: 22219475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amrinone enhances myocardial contractility and improves left ventricular diastolic function in conscious and anesthetized chronically instrumented dogs.
    Pagel PS; Hettrick DA; Warltier DC
    Anesthesiology; 1993 Oct; 79(4):753-65. PubMed ID: 8214755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.